Breathe Well Live Well
|
Mississippi's Medicaid program adds coverage for Aerocrine's FeNO testing in …
EON: Enhanced Online News (press release) Asthma is a chronic inflammatory disease of the airways that affects more than 300 million people worldwide, many of whom are children. FeNO is a marker of the underlying airway inflammation associated with asthma, and Aerocrine has developed a method … |
View full post on asthma – Google News
|
Mississippi's Medicaid program adds coverage for Aerocrine's FeNO testing in …
MarketWatch (press release) Asthma is a chronic inflammatory disease of the airways that affects more than 300 million people worldwide, many of whom are children. FeNO is a marker of the underlying airway inflammation associated with asthma, and Aerocrine has developed a method … |
View full post on asthma – Google News